Yihong Guan
About Yihong Guan
Yihong Guan is a scientist specializing in cell engineering, currently working at Arcus Biosciences since 2021. He has developed significant research contributions, including a molecular weight estimation equation for acidic peptides and a synthetic lethality strategy for leukemia treatment.
Work at Arcus Biosciences
Yihong Guan has been employed at Arcus Biosciences as a Scientist in Cell Engineering since 2021. Located in Hayward, California, he focuses on advancing research in cell engineering. His role involves applying his expertise in gene editing and cancer research to develop innovative therapeutic strategies.
Education and Expertise
Yihong Guan holds a Bachelor's Degree in Veterinary Sciences from Zhejiang University, completed from 2006 to 2010. He furthered his education at the same institution, earning a PhD in Development Biology from 2010 to 2015. Additionally, he participated in research training in molecular biology at Purdue University in 2009. His expertise includes gene editing using CRISPR/Cas9 technology and cancer research.
Background
Before joining Arcus Biosciences, Yihong Guan worked as a Postdoctoral Researcher at Cleveland Clinic from 2017 to 2021 and at Case Western Reserve University from 2015 to 2017. His research has focused on cancer therapeutics, specifically targeting TET2 DNA dioxygenases deficient leukemia and evaluating the efficacy of Ascorbic Acid in treating TET2 mutant myeloid blood cancers.
Achievements
Yihong Guan has made significant contributions to the field of cancer research, including the development of a synthetic lethality strategy for leukemia treatment. He has published 13 peer-reviewed research articles, with five as the first author, and presented 34 conference papers. He holds a patent related to his research work, showcasing his innovative contributions to science.